BBIO vs. SPY
Compare and contrast key facts about BridgeBio Pharma, Inc. (BBIO) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBIO or SPY.
Correlation
The correlation between BBIO and SPY is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BBIO vs. SPY - Performance Comparison
Key characteristics
BBIO:
-0.55
SPY:
2.17
BBIO:
-0.55
SPY:
2.88
BBIO:
0.94
SPY:
1.41
BBIO:
-0.44
SPY:
3.19
BBIO:
-0.85
SPY:
14.10
BBIO:
36.27%
SPY:
1.90%
BBIO:
55.65%
SPY:
12.39%
BBIO:
-92.80%
SPY:
-55.19%
BBIO:
-63.39%
SPY:
-3.19%
Returns By Period
In the year-to-date period, BBIO achieves a -34.38% return, which is significantly lower than SPY's 24.97% return.
BBIO
-34.38%
14.97%
-3.18%
-31.71%
-8.62%
N/A
SPY
24.97%
-0.32%
8.25%
26.85%
14.57%
12.92%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BBIO vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BridgeBio Pharma, Inc. (BBIO) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBIO vs. SPY - Dividend Comparison
BBIO has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 0.87%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBIO BridgeBio Pharma, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 0.87% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
BBIO vs. SPY - Drawdown Comparison
The maximum BBIO drawdown since its inception was -92.80%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for BBIO and SPY. For additional features, visit the drawdowns tool.
Volatility
BBIO vs. SPY - Volatility Comparison
BridgeBio Pharma, Inc. (BBIO) has a higher volatility of 20.20% compared to SPDR S&P 500 ETF (SPY) at 3.64%. This indicates that BBIO's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.